Osteoporosis
Conditions
Interventions
HT group:N/A
non-HT group:N/A
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Clinical diagnosis of bone loss or osteoporosis (bone density test using DXA, T-value 2 years) (4) Regular use of diphosphate or disummab or teriparatide for anti-osteoporosis therapy (5) Willing to participate in this study
Exclusion criteria
Exclusion criteria: (1) Previous history of thyroid dysfunction (2) History of thyroid tumor (3) Poor general conditions are not suitable for inclusion in this study (4) Withdrawal from the study for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mass;Thyroglobulin antibody;Thyroid peroxidase antibody;Bone mineral density-T value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thyroid stimulating hormone;Free thyroxine;bone alkaline phosphatase;Total type 1 collagen amino acid extended peptide;Type I collagen hydroxy terminal peptide ß Degradation products;serem calcium;serium phosphate;parathyroid hormone; | — |
Countries
China
Contacts
Public ContactXijie Yu
West China Hospital of Sichuan University
Outcome results
None listed